Exploring the potential mechanisms of impairment on genitourinary system associated with coronavirus disease 2019 infection: Bioinformatics and molecular simulation analyses

Exploring the potential mechanisms of impairment on genitourinary system associated with coronavirus disease 2019 infection: Bioinformatics and molecular simulation analyses

Objective: The novel coronavirus (severe acute respiratory syndrome coronavirus 2) has been spreading worldwide since December 2019, posing a serious danger to human health and socioeconomic development. A large number of clinical trials have revealed that coronavirus disease 2019 (COVID-19) results...

Full description

Bibliographic Details
Main Authors:	Kai Zhao, Dong Zhang, Xinchi Xu, Shangqian Wang, Zhanpeng Liu, Xiaohan Ren, Xu Zhang, Zhongwen Lu, Shancheng Ren, Chao Qin
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Series:	Asian Journal of Urology
Subjects:	Coronavirus disease 2019 Severe acute respiratory syndrome coronavirus 2 Angiotensin-converting enzyme 2 Transmembrane serine protease 2 CD147 Genitourinary organ
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214388223000231

Similar Items

SARS-CoV-2 effects in the genitourinary system and prospects of sex hormone therapy
by: Kuangzheng Liu, et al.
Published: (2021-07-01)

Unraveling the Link between Periodontitis and Coronavirus Disease 2019: Exploring Pathogenic Pathways and Clinical Implications
by: En-Chin Lin, et al.
Published: (2023-10-01)

Smoke and Spike: Benzo[a]pyrene Enhances SARS‐CoV‐2 Infection by Boosting NR4A2‐Induced ACE2 and TMPRSS2 Expression
by: Wenbin Liu, et al.
Published: (2023-09-01)

Manifestations of coronavirus infection disease-19 in anterior eye segment: An up-to-date review
by: Basheer Abdullah Marzoog
Published: (2024-01-01)

Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study
by: Kristina Schönfelder, et al.
Published: (2021-04-01)

Impact of Diabetes in Patients Diagnosed With COVID-19
by: Mohamed Abu-Farha, et al.
Published: (2020-12-01)

TMPRSS2 Correlated With Immune Infiltration Serves as a Prognostic Biomarker in Prostatic Adenocarcinoma: Implication for the COVID-2019
by: Lianxiang Luo, et al.
Published: (2020-09-01)

A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine
by: Lorella Paparo, et al.
Published: (2022-01-01)

Corrigendum: Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract
by: Roberto Berni Canani, et al.
Published: (2021-11-01)

Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract
by: Roberto Berni Canani, et al.
Published: (2021-07-01)

Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters
by: Mohammad Rubayet Hasan, et al.
Published: (2021-12-01)

Coronavirus disease 2019 and cardiovascular disease
by: Jenn-Yeu Song, et al.
Published: (2023-01-01)

RECURRENT OF TMPRSS2 GENETIC POLYMORPHISM AND ITS ROLE IN IRAQI PATIENTS WITH PROSTATE CANCER
by: Ammar K. A., et al.
Published: (2022-04-01)

Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
by: Jordan Swiderski, et al.
Published: (2023-05-01)

Potential adverse effects of coronavirus disease 2019 on the cardiovascular system
by: Bing-Yin Wang, et al.
Published: (2021-01-01)

Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells
by: Ahmed Bakillah, et al.
Published: (2022-08-01)

Variations in levels of ACE2 and TMPRSS2 receptors among COVID-19
by: Dalia Zanaty, et al.
Published: (2024-02-01)

Can coronavirus disease 2019 effect on human reproduction?
by: Ali Abdolrazaghnejad, et al.
Published: (2022-01-01)

Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis
by: Zhidan Yu, et al.
Published: (2021-07-01)

Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19
by: Sepehr Shafiee, et al.
Published: (2021-08-01)

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019
by: Chunsheng Zhu, et al.
Published: (2020-08-01)

Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019
by: Mudasir S. Andrabi, et al.
Published: (2020-11-01)

Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence
by: Tom Gallagher, et al.
Published: (2012-04-01)

Eye Washing Downregulated Angiotensin-Converting Enzyme 2 in Conjunctival Tissue Samples from Smokers
by: Hiroshi Fujishima, et al.
Published: (2023-12-01)

Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review
by: Apichet Sirinawasatien, et al.
Published: (2021-11-01)

Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2
by: John M. Matsoukas, et al.
Published: (2022-07-01)

Renin-angiotensin system in the pathogenesis of COVID-19 and possible drug targets
by: Sujay Halkur Shankar, et al.
Published: (2021-01-01)

Herbal medicines in the treatment of coronavirus disease 2019 (COVID-19)
by: Audrey Tolouian, et al.
Published: (2021-05-01)

Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein
by: Reji Manjunathan, et al.
Published: (2022-05-01)

Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro
by: Omonike A. Olaleye, et al.
Published: (2021-03-01)

Association of Cigarette Smoking, COPD, and Lung Cancer With Expression of SARS-CoV-2 Entry Genes in Human Airway Epithelial Cells
by: Junping Yin, et al.
Published: (2020-12-01)

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
by: Enrique Ambrocio-Ortiz, et al.
Published: (2021-08-01)

Decreased Heart Rate Variability in COVID-19
by: Chengfen Yin, et al.
Published: (2022-12-01)

Curcumin as a potential multiple-target inhibitor against SARS-CoV-2 infection: A detailed interaction study using quantum chemical calculations
by: Kumar Sumit
Published: (2023-01-01)

Potential use of the S-protein–Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019
by: Long Feng, et al.
Published: (2022-11-01)

New hope for treatment of respiratory involvement following COVID-19 by bromhexine
by: Abdolrazagh Barzegar, et al.
Published: (2021-05-01)

COVID-19 pandemic; transmembrane protease serine 2 (TMPRSS2) inhibitors as potential drugs.
by: Jerzy Jankun
Published: (2020-04-01)

Assessment and strategy development for SARS-CoV-2 screening in wildlife: A review
by: Jignesh Italiya, et al.
Published: (2023-06-01)

Exploring the causes of mild COVID-19 involvement in pediatric patients
by: A. Naserghandi, et al.
Published: (2020-09-01)

Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
by: Rami Sommerstein, et al.
Published: (2020-04-01)